The use of omega‐3 fatty acids in the treatment of oral diseases
Authors:
- Mariane Maffei AzumaMAMariane Maffei Azuma
- Carolina de Barros Morais CardosoCCCarolina de Barros Morais Cardoso
- Cristiane Cantiga da SilvaCSCristiane Cantiga da Silva
- Pedro Henrique Chaves de OliveiraPOPedro Henrique Chaves de Oliveira
- Rogério de Castilho JacintoRJRogério de Castilho Jacinto
- Ana Cristina AndradaAAAna Cristina Andrada
- Luciano Tavares Angelo CintraLCLuciano Tavares Angelo Cintra
- 6 October 2020
- journal article
- review article
- Published by Wiley in Oral Diseases
- Vol. 28 (2) , 264-274
Abstract
Omega‐3 polyunsaturated fatty acids (ω‐3 PUFAs) have been reported to exert important roles in the inflammatory response. There are many inflammatory diseases in dentistry which support the administration of ω‐3 PUFAs as an adjunct therapy during the treatment of these diseases. The aim of this review was to evaluate the use of ω‐3 PUFAs as an adjuvant therapy during the treatment of buccal diseases. The review showed that supplementation with ω‐3 PUFAs was used for treatment of gingivitis, periodontal diseases, apical periodontitis, stomatitis, and orthodontic tooth movement. The results indicate that ω‐3 PUFAs decreased the number of pro‐inflammatory mediators in the gingival tissues of individuals with gingivitis and periodontitis. In apical periodontitis, the supplementation suppressed bone resorption and promoted bone formation in the periapical area of rats. During orthodontic movement, the supplementation showed a decrease of bone resorption in rats. It also showed that painful symptoms of recurrent aphthous stomatitis were alleviated in supplemented patients. In conclusion, the ω‐3 PUFAs may be used as an adjuvant therapy in the treatment of inflammatory diseases that affect the oral cavity. However, more studies are required to elucidate the role of ω‐3 PUFAs in decreasing oral cavity inflammatory processes.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/26390‐0, 2015/03054‐0)
This publication has 56 references indexed in Scilit:
- Understanding Resolvin Signaling Pathways to Improve Oral HealthInternational Journal of Molecular Sciences, 2013
- Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fishThe American Journal of Clinical Nutrition, 2012
- Effect of dietary omega‐3 polyunsaturated fatty acids on experimental periodontitis in the mouseJournal of Periodontal Research, 2009
- Leukocyte numbers and function in subjects eating n-3 enriched foods: selective depression of natural killer cell levelsArthritis Research & Therapy, 2008
- Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acidJournal of Cellular Physiology, 2007
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007
- The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibitionProceedings of the National Academy of Sciences, 2006
- Upregulation of duodenal calcium absorption by poly-unsaturated fatty acids: events at the basolateral membraneMedical Hypotheses, 2001
- Nuclear Factor kB Is Activated by Arachidonic Acid but Not by Eicosapentaenoic AcidBiochemical and Biophysical Research Communications, 1996
- Biochemical aspects of orthodontic tooth movement I. Cyclic nucleotide and prostaglandin concentrations in tissues surrounding orthodontically treated teeth in vivoAmerican Journal of Orthodontics and Dentofacial Orthopedics, 1986